# Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

> **NCT00244595** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 235 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** candsartan cilexetil

## Key facts

- **NCT ID:** NCT00244595
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 235 (—)
- **Last updated:** 2009-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244595, "Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00244595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*